OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,309,520 | -31.9% | 6,468,000 | +11.9% | 6.61% | -7.4% |
| Q2 2023 | $29,824,800 | -7.3% | 5,780,000 | -5.3% | 7.13% | -26.0% |
| Q1 2023 | $32,178,093 | +88.5% | 6,105,900 | +0.5% | 9.64% | +62.4% |
| Q4 2022 | $17,070,750 | -36.4% | 6,075,000 | -6.0% | 5.94% | -46.4% |
| Q3 2022 | $26,830,000 | +11.7% | 6,465,000 | +8.2% | 11.08% | +2.4% |
| Q2 2022 | $24,019,000 | -18.8% | 5,974,800 | 0.0% | 10.83% | +17.9% |
| Q1 2022 | $29,575,000 | -29.0% | 5,974,800 | 0.0% | 9.18% | +4.0% |
| Q4 2021 | $41,644,000 | -35.7% | 5,974,800 | -7.8% | 8.83% | -27.0% |
| Q3 2021 | $64,800,000 | -29.5% | 6,480,000 | 0.0% | 12.10% | -20.7% |
| Q2 2021 | $91,886,000 | -13.6% | 6,480,000 | 0.0% | 15.26% | -2.3% |
| Q1 2021 | $106,337,000 | -21.1% | 6,480,000 | -0.5% | 15.62% | -11.3% |
| Q4 2020 | $134,758,000 | +195.9% | 6,510,000 | +8.8% | 17.60% | +97.6% |
| Q3 2020 | $45,540,000 | -8.6% | 5,984,200 | 0.0% | 8.91% | -11.5% |
| Q2 2020 | $49,848,000 | +96.6% | 5,984,200 | +16.8% | 10.07% | +49.8% |
| Q1 2020 | $25,356,000 | +25.7% | 5,122,500 | +0.3% | 6.72% | +69.7% |
| Q4 2019 | $20,175,000 | +139.2% | 5,107,500 | +84.1% | 3.96% | +29.8% |
| Q3 2019 | $8,436,000 | -35.0% | 2,775,000 | -5.9% | 3.05% | -22.9% |
| Q2 2019 | $12,980,000 | +72.1% | 2,950,000 | +55.3% | 3.96% | +89.4% |
| Q1 2019 | $7,543,000 | +37.0% | 1,900,000 | +137.5% | 2.09% | +49.2% |
| Q3 2018 | $5,504,000 | -26.6% | 800,000 | -28.0% | 1.40% | -27.9% |
| Q2 2018 | $7,499,000 | +46.9% | 1,111,000 | +102.0% | 1.94% | -23.6% |
| Q1 2017 | $5,104,000 | +551.9% | 550,000 | +487.6% | 2.54% | +451.0% |
| Q4 2016 | $783,000 | -39.2% | 93,600 | -64.0% | 0.46% | -46.4% |
| Q2 2016 | $1,287,000 | – | 260,000 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |